MEI Pharma Inc (NASDAQ:MEIP)
| 8.92 Data as of May 17 |  -0.07 / -0.78%Today’s Change | 1.98 Today|||52-Week Range 13.18 | +27.42% Year-to-Date |
Latest MEIP News | Press Releases
| 8 Stocks Under $10 Trending Sharply Higher May 14 / TheStreet.com |
Today’s Trading
| Previous close | 8.99 |
| Today’s open | 8.96 |
| Day’s range | 8.67 - 9.02 |
| Volume | 16,615 |
| Average volume (3 months) | 85,501 |
| Market cap | $152.7M |
| Dividend yield | -- |
Data as of 3:59pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | +37.08% |
| Earnings growth (this year) | +63.39% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 6.63 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OMEROmeros Corp | +0.05 | +0.98% |
| OGXIOncoGenex Pharmaceut... | +0.08 | +0.77% |
| HZNPHorizon Pharma Inc | -0.01 | -0.41% |
| AVEOAveo Pharmaceuticals... | +0.20 | +7.12% |
Data as of 4:00pm ET, 05/17/2013
Financials
| Last reporting date | May 14, 2013 |
| EPS forecast (this quarter) | -$0.21 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$7.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Daniel P. Gold, PhD |
Chief Financial Officer & Secretary Thomas M. Zech, MBA |
Corporate headquarters San Diego, California |
Forecasts
